Back to trial detailsIntake questionnaire
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
Applying to Abramson Cancer Center of the University of Pennsylvania · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.
0 of 4 answered